Prevalence of infection with human herpesvirus 8/Kaposi's sarcoma herpesvirus in rural South Africa

South African Medical Journal

Volumn 89, Issue 5, 1999, Pages 554-557

  Wilkinson, David ^a   Sheldon, Julie ^b   Gilks, Charles F ^b   Schulz, Thomas F ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFANT; MAJOR CLINICAL STUDY; MALE; RURAL AREA; VIRUS TRANSMISSION;

ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; PREVALENCE; RURAL POPULATION; SARCOMA, KAPOSI; SOUTH AFRICA;

EID: 0032828485     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
2. Boshoff C, Whitby D, Hatzioannou T, et al. Kaposi's sarcoma associated herpesvirus in HIV-negative Kaposi sarcoma. Lancet 1995; 345: 1043-1044.
3. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332: 1181-1185.
4. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995; 1: 707-708.
5. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences are present in African endemic and AIDS-associated Kaposi's sarcoma. Arch Intern Med 1996; 156: 202-204.
6. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals predicts progression to Kaposi's sarcoma. Lancet 1995; 346: 799-802.
7. Moore PS, Kingsley LA, Holmberg SD, et al. KSHV infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10: 175-180.
8. Lefrere JJ, Meyohas MC, Mariotti M, Meynard JL, Thauvin M, Frottier J. Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J Infect Dis 1996; 174: 283-287.
9. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma associated herpesvirus infects endothelial and spindle cells. Nat Med 1995; 1: 1274-1278.
10. Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumour cells. J Virol 1977; 71: 715-719.
11. Sturzl M, Blasig C, Schreier A, et al. Expression of HHV-8 latency associated To. 7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma (KS). Int J Cancer 1997; 72: 68-71..
12. Orenstein JM, Alkan S, Blauvelt A, et al. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 1997; 11; F35-745.
13. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroprevalence of human herpesvirus 8 (HHV 8): Distribution of infection in Kaposi's sarcoma risk groups and evidence of sexual transmission. Nat Med 1996; 2: 918-924.
14. Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated hepesvirus) among HIV-seropositive and high risk HIV-seronegative women. JAMA 1997; 277: 478-481.
15. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion of antibodies to Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233-241.
16. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma-associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 1133-1138.
17. Lennette ET, Blackboum DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858-861.
18. Melbye M, Cook PM, Hjalgrim H, et al. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998; 77: 543-548.
19. Gao SJ, Kingsley L, Li M, et al. Seroprevalence of KSHV antibodies among North Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2: 925-928.
20. National Cancer Registry. Cancer in South Africa, 1992. Johannesburg: National Cancer Registry, South African Institute for Medical Research 1997.
21. Sitas F, Taylor L, Madhoo J, Cooper K, Carrara H. Occurrence of human herpes virus 8 in Kaposi's sarcoma and other tumours in South Africa. S Afr Med J 1997; 87: 1020.
22. Coleman RL, Wilkinson D. Increasing HIV prevalence in a rural district of South Africa: 1992 -1995. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 50-53.
23. Wilkinson D, Abdool Karim SS, Harrison A, et al. Unrecognised sexually transmitted infections in rural South African women - the hidden epidemic. Bull World Health Organ 1999 (in press).
24. Mayama S, Cuevas L, Sheldon J, et al. Prevalence of Kaposi's sarcoma associated herpesvirus (Human herpesvirus 8) in a young Ugandan population. Int J Cancer 1998 (in press).
25. Boldough I, Szaniszlo P, Bresnahan WA, Flaitz CM, Nichols MC, Albrecht T. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin Infect Dis 1996; 23: 406-407.
26. Vieira JD, Hunag L, Koelle DM, Corey L. Transmissible Kaposi's-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 1997; 71: 7083-7087.